Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy
详细信息    查看全文
  • 作者：Yoshitsugu Kaku (1)
    Yasufumi Ohtsuka (2)
    Yasuhiro Komatsu (3)
    Toshiyuki Ohta (4)
    Takuhito Nagai (5)
    Hiroshi Kaito (6)
    Shuji Kondo (7)
    Yohei Ikezumi (8)
    Seiji Tanaka (9)
    Shinsuke Matsumoto (10)
    Mayumi Sako (11)
    Kazushi Tsuruga (12)
    Koichi Nakanishi (13)
    Koichi Kamei (14)
    Hiroshi Saito (15)
    Shuichiro Fujinaga (16)
    Yuko Hamasaki (17)
    Hiroko Chikamoto (18)
    Kenji Ishikura (19)
    Kazumoto Iijima (6)

    1. Department of Nephrology     ; Fukuoka Children鈥檚 Hospital ; 5-1-1 Kashii-Teriha ; Higashi-ku ; Fukuoka ; Japan
    2. Department of Pediatrics     ; Faculty of Medicine ; Saga University ; Saga ; Japan
    3. Division of Nephrology     ; Department of Medicine ; St. Luke鈥檚 International Hospital ; Tokyo ; Japan
    4. Department of Pediatric Nephrology     ; Hiroshima Prefectural Hospital ; Hiroshima ; Japan
    5. Department of Nephrology     ; Aichi Children鈥檚 Health and Medical Center ; Aichi ; Japan
    6. Department of Pediatrics     ; Kobe University Graduate School of Medicine ; Kobe ; Japan
    7. Department of Pediatrics     ; Institute of Health Bioscience ; Tokushima University ; Tokushima ; Japan
    8. Department of Pediatrics     ; Niigata University Medical and Dental Hospital ; Niigata ; Japan
    9. Department of Pediatrics and Child Health     ; Kurume University Medical Center ; Fukuoka ; Japan
    10. Department of Pediatrics     ; Matsudo City Hospital Children鈥檚 Medical Center ; Chiba ; Japan
    11. Division for Clinical Trials     ; Department of Development Strategy ; Center for Social and Clinical Research ; National Research Institute for Child Health and Development ; Tokyo ; Japan
    12. Department of Pediatrics     ; Hirosaki University Graduate School of Medicine ; Hirosaki ; Japan
    13. Department of Pediatrics     ; Wakayama Medical University ; Wakayama ; Japan
    14. Department of Nephrology and Rheumatology     ; National Center for Child Health and Development ; Tokyo ; Japan
    15. Department of Pediatrics     ; Nihon University School of Medicine ; Tokyo ; Japan
    16. Division of Nephrology     ; Saitama Children鈥檚 Medical Center ; Saitama ; Japan
    17. Department of Pediatric Nephrology     ; Toho University Faculty of Medicine ; Tokyo ; Japan
    18. Department of Pediatric Nephrology     ; Tokyo Women鈥檚 Medical University ; School of Medicine ; Tokyo ; Japan
    19. Department of Nephrology     ; Tokyo Metropolitan Children鈥檚 Medical Center ; 2-8-29 Musashidai ; Fuchu ; Tokyo ; 183-8561 ; Japan
  • 刊名：Clinical and Experimental Nephrology
  • 出版年：2015
  • 出版时间：February 2015
  • 年：2015
  • 卷：19
  • 期：1
  • 页码：34-53
  • 全文大小：774 KB
  • 参考文献：1. Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Kaku Y, Iijima K. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy, clinical and experimental nephrology. doi:10.1007/s10157-014-1030-x .
    2. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA. Management of childhood onset nephrotic syndrome. Pediatrics. 2009;124(2):747鈥?7. CrossRef
    3. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2008;45(3):203鈥?4.
    4. Vasudevan A, Mantan M, Bagga A. Management of edema in nephrotic syndrome. Indian Pediatr. 2004;41(8):787鈥?5.
    5. Park SJ, Shin JI. Complications of nephrotic syndrome. Korean J Pediatr. 2011;54(8):322鈥?. CrossRef
    6. Doucet A, Favre G, Desch锚nes G. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol. 2007;22(12):1983鈥?0. CrossRef
    7. Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635鈥?2. CrossRef
    8. Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Baltimore: Lippincott Williams and Wilkins; 2009.
    9. Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet. 1995;15:148鈥?2.
    10. Wang SJ, Tsau YK, Lu FL, Chen CH. Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr Taiwan. 2000;41:179鈥?3.
    11. Vande Walle JG, Donckerwolcke RA, Koomans HA. Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol. 1999;10:323鈥?1.
    12. Van de Walle JG, Donckerwolcke RA, Greidanus TB, Joles JA, Koomans HA. Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant. 1996;11:2202鈥?. CrossRef
    13. Reid CJ, Marsh MJ, Murdoch IM, Clark G. Nephrotic syndrome in childhood complicated by life threatening pulmonary oedema. BMJ. 1996;312:36鈥?. CrossRef
    14. Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993;91:1142鈥?.
    15. Agarwal N, Phadke KD, Garg I, Alexander P. Acute renal failure in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2003;18:1289鈥?2. CrossRef
    16. Loghman-Adham M, Siegler RL, Pysher TJ. Acute renal failure in idiopathic nephrotic syndrome. Clin Nephrol. 1997;47:76鈥?0.
    17. Sakarcan A, Timmons C, Seikaly MG. Reversible idiopathic acute renal failure in children with primary nephrotic syndrome. J Pediatr. 1994;125(5 Pt 1):723鈥?. CrossRef
    18. Gurgoze MK, Gunduz Z, Poyrazoglu MH, Dursun I, Uzum K, Dusunsel R. Role of sodium during formation of edema in children with nephrotic syndrome. Pediatr Int. 2011;53:50鈥?. CrossRef
    19. D枚nmez O, Mir S, Ozy眉rek R, Cura A, Kabasakal C. Inferior vena cava indices determine volume load in minimal lesion nephrotic syndrome. Pediatr Nephrol. 2001;16:251鈥?. CrossRef
    20. Tabel Y, Mungan I, Karakurt C, Kocak G, Gungor S. Is edema in minimal change disease of childhood really hypovolemic? Int Urol Nephrol. 2008;40:757鈥?1. CrossRef
    21. Donckerwolcke RA, France A, Raes A, Vande Walle J. Distal nephron sodium鈥損otassium exchange in children with nephrotic syndrome. Clin Nephrol. 2003;59:259鈥?6. CrossRef
    22. Kapur G, Valentini RP, Imam AA, Jain A, Mattoo TK. Serum osmolal gap in patients with idiopathic nephrotic syndrome and severe edema. Pediatrics. 2007;119(6):e1404鈥?. CrossRef
    23. Bozzetto S, Piccoli A, Montini G. Bioelectrical impedance vector analysis to evaluate relative hydration status. Pediatr Nephrol. 2010;25:329鈥?4. CrossRef
    24. van der Vorst MM, Kist JE, van der Heijden AJ, Burggraaf J. Diuretics in pediatrics: current knowledge and future prospects. Paediatr Drugs. 2006;8(4):245鈥?4. CrossRef
    25. Eades SK, Christensen ML. The clinical pharmacology of loop diuretics in the pediatric patient. Pediatr Nephrol. 1998;12(7):603鈥?6. CrossRef
    26. Prandota J. Pharmacokinetics of furosemide urinary elimination by nephrotic children. Pediatr Res. 1983;17(2):141鈥?. CrossRef
    27. Brater DC. Diuretic therapy. N Engl J Med. 1998;339(6):387鈥?5. CrossRef
    28. Garin EH. A comparison of combinations of diuretics in nephrotic edema. Am J Dis Child. 1987;141:769鈥?1.
    29. Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone鈥攁 prospective study. Clin J Am Soc Nephrol. 2009;4:907鈥?3. CrossRef
    30. Dharmaraj R, Hari P, Bagga A. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009;24:775鈥?2. CrossRef
    31. Lewis MA, Awan A. Mannitol and frusemide in the treatment of diuretic resistant oedema in nephrotic syndrome. Arch Dis Child. 1999;80:184鈥?. CrossRef
    32. Kanzaki M, Wada J, Kikumoto Y, Akagi S, Nakao K, Sugiyama H, Makino H. The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial. Int J Nephrol Renovasc Dis. 2012;5:91鈥?.
    33. Bircan Z, Kervancio臒lu M, Katar S, Vitrinel A. Does albumin and furosemide therapy affect plasma volume in nephrotic children? Pediatr Nephrol. 2001;16:497鈥?. CrossRef
    34. Fauchald P, Noddeland H, Norseth J. An evaluation of ultrafiltration as treatment of diuretic-resistant oedema in nephrotic syndrome. Acta Med Scand. 1985;217:127鈥?1. CrossRef
    35. Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int. 1986;29:572鈥?. CrossRef
    36. Rosenberg ME, Swanson JE, Thomas BL, Hostetter TH. Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 1987;253 F1083鈥揊1090.
    37. Poortmans JR, Vanderstraeten J. Kidney function during exercise in healthy and diseased humans. An update. Sports Med. 1994;18:419鈥?7. CrossRef
    38. Nagasaka Y, Yogi S, Taguchi H, Yoshida Y, Fujiwara Y. Participation to swimming lessons and relapse of nephrotic syndrome [in Japanese]. J Jpn Pediatr Soc. 1986;90:2737鈥?1.
    39. Nagasaka Y. The effect of swimming on renal function in children with renal disease [in Japanese]. Jpn J Nephrol. 1986;28:1465鈥?0.
    40. Miura H, Fukui H, Hayano K, Otsuka Y, Hattori S. A case of minimal change nephrotic syndrome associated with acute renal failure after excessive exercise. Nihon Jinzo Gakkai Shi. 1993;35:387鈥?1.
    41. Kayali F, Najjar R, Aswad F, Matta F, Stein PD. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med. 2008;121(3):226鈥?0. CrossRef
    42. Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand. 1986;75:804鈥?0. CrossRef
    43. Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) Study. J Pediatr. 2009;155:105鈥?0. CrossRef
    44. Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974鈥?996). Pediatr Nephrol. 2000;15:74鈥?. CrossRef
    45. Hegarty J, Mughal MZ, Adams J, Webb NJ. Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int. 2005;68:2304鈥?. CrossRef
    46. Foster BJ, Shults J, Zemel BS, Leonard MB. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2006;21:973鈥?0. CrossRef
    47. Merritt RJ, Hack SL, Kalsch M, Olson D. Corticosteroid therapy-induced obesity in children. Clin Pediatr (Phila). 1986;25:149鈥?2. CrossRef
    48. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362鈥?4. CrossRef
    49. Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, Goldberg-Gell R, Burgert TS, Cali AM, Weiss R, Caprio S. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA. 2007;297:2697鈥?04. CrossRef
    50. Goto M, Ninomiya M, Uemura O, Matsuyama K, Ito Y, Hataya H, Ito S, Yamakawa S, Ishikawa T, Honda M. A questionnaire survey on exercise limitation in children with kidney disease [in Japanese]. Jpn J Pediatr Nephrol. 2012;25(6):17.
    51. van Staa TP, Cooper C, Leufkens HG, Bishop N. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res. 2003;18(5):913鈥?. CrossRef
    52. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med. 2004;351:868鈥?5. CrossRef
    53. Freundlich M, Jofe M, Goodman WG, Salusky IB. Bone histology in steroid-treated children with non-azotemic nephrotic syndrome. Pediatr Nephrol. 2004;19:400鈥?. CrossRef
    54. Reyes ML, Hern谩ndez MI, King A, Vinet AM, Vogel A, Lagomarsino E, Mericq MV, M茅ndez C, Gederlini A, Talesnik E. Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures. Clin Exp Rheumatol. 2007;25:329鈥?5.
    55. Rudge S, Hailwood S, Horne A, Lucas J, Wu F, Cundy T. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology (Oxford). 2005;44(6):813鈥?. CrossRef
    56. Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol. 2006;21:350鈥?. CrossRef
    57. Kaiser BA, Polinsky MS, Palmer JA, Dunn S, Mochon M, Flynn JT, Baluarte HJ. Growth after conversion to alternate-day corticosteroids in children with renal transplants: a single-center study. Pediatr Nephrol. 1994;8:320鈥?. CrossRef
    58. Broyer M, Guest G, Gagnadoux MF. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr. 1992;120:721鈥?. CrossRef
    59. Guest G, Broyer M. Growth after renal transplantation: correlation with immunosuppressive therapy. Pediatr Nephrol. 1991;5:143鈥?. CrossRef
    60. Hokken-Koelega AC, Van Zaal MA, de Ridder MA, Wolff ED, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Drop SL. Growth after renal transplantation in prepubertal children: impact of various treatment modalities. Pediatr Res. 1994;35:367鈥?1. CrossRef
    61. Jabs K, Sullivan EK, Avner ED, Harmon WE. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation. 1996;61:31. CrossRef
    62. Yamashita F, Funatsu T, Nagayama K, Arihiro H, Anan S. Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study. Kurume Med J. 1971;18:153鈥?0. CrossRef
    63. Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2000;27:2018鈥?4.
    64. Simmonds J, Trompeter R, Tullus K. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Arch Dis Child. 2010;95:146鈥?. CrossRef
    65. Rivkees SA, Danon M, Herrin J. Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. J Pediatr. 1994;125:322鈥?.
    66. Bachmann HJ, Schildberg P, Olbing H, Kr盲mer D, Waubke T. Cortisone cataract in children with nephrotic syndrome. Eur J Pediatr. 1977;124:277鈥?3. CrossRef
    67. Brocklebank JT, Harcourt RB, Meadow SR. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Child. 1982;57:30鈥?.
    68. Forman AR, Loreto JA, Tina LU. Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome. Am J Ophthalmol. 1977;84:75鈥?. CrossRef
    69. Limaye SR, Pillai S, Tina LU. Relationship of steroid dose to degree of posterior subcapsular cataracts in nephrotic syndrome. Ann Ophthalmol. 1988;20:225鈥?.
    70. Kobayashi Y, Akaishi K, Nishio T, Kobayashi Y, Kimura Y. Posterior subcapsular cataract in nephrotic children receiving steroid therapy. Am J Dis Child. 1974;128:671鈥?.
    71. Hayasaka Y, Hayasaka S, Matsukura H. Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy. Ophthalmologica. 2006;220:181鈥?. CrossRef
    72. Kaye LD, Kalenak JW, Price RL, Cunningham R. Ocular implications of long-term prednisone therapy in children. J Pediatr Ophthalmol Strabismus. 1993;30:142鈥?.
    73. Ng JS, Wong W, Law RW, Hui J, Wong EN, Lam DS. Ocular complications of paediatric patients with nephrotic syndrome. Clin Exp Ophthalmol. 2001;29:239鈥?3. CrossRef
    74. Chen CH, Chen CM. Lee PP. The effect of betamethasone on intraocular pressure in nephrotic children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1994;35:197鈥?01.
    75. Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health. 2004;40:28鈥?2. CrossRef
    76. Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatrics. 1993;92:223鈥?.
    77. Uncu N, B眉lb眉l M, Yildiz N, Noyan A, Ko艧an C, Kavuk莽u S, Cali艧kan S, G眉nd眉z Z, Be艧ba艧 N. G眉r G眉ven A. Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr. 2010;169:73鈥?. CrossRef
    78. Tain YL, Lin G, Cher TW. Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatr Nephrol. 1999;13:835鈥?. CrossRef
    79. Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J. Massachusetts Department of Public Health Epidemiologists. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. 2005;24:17鈥?3. CrossRef
    80. Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol. 2008;23:1107鈥?3. CrossRef
    81. Aoun B, Wannous H, Az茅ma C, Ulinski T. Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data. Pediatr Nephrol. 2010;25:1773鈥?. CrossRef
    82. Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI. Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2011;16(29):6834鈥?. CrossRef
    83. Poyrazo臒lu HM, D眉艧眉nsel R, G眉nd眉z Z, Patiro臒lu T, K枚kl眉 S. Antibody response to influenza A vaccination in children with nephrotic syndrome. Pediatr Nephrol. 2004;19:57鈥?0. CrossRef
    84. Laube GF, Berger C, Goetschel P, Leumann E, Neuhaus TJ. Immunization in children with chronic renal failure. Pediatr Nephrol. 2002;17:638鈥?2. CrossRef
    85. Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA, Southwest Pediatric Nephrology Study Group. Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J Pediatr. 2003;142:145鈥?. CrossRef
    86. Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol. 2000;14:305鈥?. CrossRef
    87. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Long-term outcome for children with minimal-change nephrotic syndrome. Lancet. 1985;1:368鈥?0. CrossRef
    88. Wynn SR, Stickler GB, Burke EC. Long-term prognosis for children with nephrotic syndrome. Clin Pediatr (Phila). 1988;27:63鈥?. CrossRef
    89. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Gr眉nfeld JP, Niaudet P. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550鈥?. CrossRef
    90. R眉th EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005;147:202鈥?. CrossRef
    91. Ishimori S, Kaito H, Ohtsubo H, Hashimoto F, Ninchoji T, Hashimura Y, Morisada N, Iijima K. Current status and complications of adult patients with childhood-onset steroid-sensitive nephrotic syndrome [in Japanese]. J Jpn Pediatr Soc. 2013;117:90鈥?.
  • 刊物类别：Medicine
  • 刊物主题：Medicine & Public Health
    Nephrology
    Internal Medicine
    Urology and Andrology
  • 出版者：Springer Japan
  • ISSN：1437-7799
文摘

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址：北京市海淀区学院路29号 邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700